JP2024156774A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024156774A5 JP2024156774A5 JP2024122258A JP2024122258A JP2024156774A5 JP 2024156774 A5 JP2024156774 A5 JP 2024156774A5 JP 2024122258 A JP2024122258 A JP 2024122258A JP 2024122258 A JP2024122258 A JP 2024122258A JP 2024156774 A5 JP2024156774 A5 JP 2024156774A5
- Authority
- JP
- Japan
- Prior art keywords
- pharma
- acceptable salt
- compound
- ceutically acceptable
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762584575P | 2017-11-10 | 2017-11-10 | |
| US62/584,575 | 2017-11-10 | ||
| US201862678723P | 2018-05-31 | 2018-05-31 | |
| US62/678,723 | 2018-05-31 | ||
| JP2020526066A JP7271538B2 (ja) | 2017-11-10 | 2018-11-08 | 低分子ｉｒｅ１阻害剤 |
| JP2023071977A JP7535335B2 (ja) | 2017-11-10 | 2023-04-26 | 低分子ｉｒｅ１阻害剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023071977A Division JP7535335B2 (ja) | 2017-11-10 | 2023-04-26 | 低分子ｉｒｅ１阻害剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024156774A JP2024156774A (ja) | 2024-11-06 |
| JP2024156774A5 true JP2024156774A5 (https=) | 2025-02-05 |
Family
ID=64477302
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020526066A Active JP7271538B2 (ja) | 2017-11-10 | 2018-11-08 | 低分子ｉｒｅ１阻害剤 |
| JP2023071977A Active JP7535335B2 (ja) | 2017-11-10 | 2023-04-26 | 低分子ｉｒｅ１阻害剤 |
| JP2024122258A Pending JP2024156774A (ja) | 2017-11-10 | 2024-07-29 | 低分子ｉｒｅ１阻害剤 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020526066A Active JP7271538B2 (ja) | 2017-11-10 | 2018-11-08 | 低分子ｉｒｅ１阻害剤 |
| JP2023071977A Active JP7535335B2 (ja) | 2017-11-10 | 2023-04-26 | 低分子ｉｒｅ１阻害剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (5) | US10745379B2 (https=) |
| EP (1) | EP3707126B1 (https=) |
| JP (3) | JP7271538B2 (https=) |
| CN (1) | CN111566089B (https=) |
| CA (1) | CA3082363A1 (https=) |
| WO (1) | WO2019094641A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3548476A4 (en) | 2016-12-02 | 2020-05-20 | Quentis Therapeutics, Inc. | SMALL MOLECULAR IRE1 INHIBITORS |
| CA3064837A1 (en) * | 2017-06-01 | 2018-12-06 | Quentis Therapeutics, Inc. | Ire1 small molecule inhibitors |
| US10745379B2 (en) | 2017-11-10 | 2020-08-18 | Cornell University | IRE1 small molecule inhibitors |
| EP3891137B1 (en) | 2018-12-03 | 2024-10-09 | Cornell University | Ire1 small molecule inhibitors |
| WO2020232401A1 (en) * | 2019-05-15 | 2020-11-19 | Cornell University | Combination therapies with ire1 small molecule inhibitors |
| WO2020252165A1 (en) * | 2019-06-11 | 2020-12-17 | Genentech, Inc. | Quinazolinyl compounds and methods of use |
| JP2021031420A (ja) * | 2019-08-21 | 2021-03-01 | 日東電工株式会社 | Ｍｙｈ９の阻害物質を用いた、がん転移抑制 |
| US20240262830A1 (en) * | 2020-02-03 | 2024-08-08 | Nimbus Iaso, Inc. | Ire1a modulators and uses thereof |
| US11840523B2 (en) | 2020-11-13 | 2023-12-12 | The Regents Of The University Of California | IRE1α inhibitors and uses thereof |
| MX2023005747A (es) | 2020-11-18 | 2023-07-28 | Deciphera Pharmaceuticals Llc | Inhibidores de gcn2 y perk quinasas y metodos de uso de los mismos. |
| CN114907350B (zh) * | 2021-02-10 | 2023-12-29 | 上海凌达生物医药有限公司 | 一类含氮稠环类化合物、制备方法和用途 |
| KR20240113496A (ko) | 2021-12-03 | 2024-07-22 | 데시페라 파마슈티칼스, 엘엘씨. | Gcn2 및 perk 키나아제 억제제로서의 헤테로고리 화합물 |
| EP4504720A4 (en) * | 2022-04-08 | 2026-03-25 | Alesta Therapeutics BV | GCN2 MODULATOR COMPOUNDS |
| GB202207721D0 (en) | 2022-05-25 | 2022-07-06 | Cerevance Ltd | Novel Compounds |
| AU2024356374A1 (en) * | 2023-10-06 | 2026-04-16 | Alesta Therapeutics BV | Compounds of gcn2 modulators |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070054916A1 (en) * | 2004-10-01 | 2007-03-08 | Amgen Inc. | Aryl nitrogen-containing bicyclic compounds and methods of use |
| US8980899B2 (en) * | 2009-10-16 | 2015-03-17 | The Regents Of The University Of California | Methods of inhibiting Ire1 |
| EP2555768B1 (en) * | 2010-04-05 | 2018-08-29 | Fosun Orinove Pharmatech, Inc. | Ire-1 inhibitors |
| US9422298B2 (en) | 2011-03-17 | 2016-08-23 | Cmg Pharmaceutical Co., Ltd. | Pyridopyrimidine derivatives and use thereof |
| MX2015003874A (es) | 2012-09-26 | 2015-12-16 | Univ California | Modulacion de ire1. |
| WO2016004254A1 (en) * | 2014-07-01 | 2016-01-07 | The Regents Of The University Of California | Combined modulation of ire1 |
| WO2016022839A1 (en) * | 2014-08-06 | 2016-02-11 | The Regents Of The University Of California | Modulators of ire1 |
| CA3016161A1 (en) | 2016-03-03 | 2017-09-08 | Cornell University | Small molecule ire1-alpha inhibitors |
| CA3064837A1 (en) * | 2017-06-01 | 2018-12-06 | Quentis Therapeutics, Inc. | Ire1 small molecule inhibitors |
| US10745379B2 (en) | 2017-11-10 | 2020-08-18 | Cornell University | IRE1 small molecule inhibitors |
-
2018
- 2018-11-08 US US16/184,916 patent/US10745379B2/en active Active
- 2018-11-08 JP JP2020526066A patent/JP7271538B2/ja active Active
- 2018-11-08 CN CN201880085863.XA patent/CN111566089B/zh active Active
- 2018-11-08 EP EP18808592.2A patent/EP3707126B1/en active Active
- 2018-11-08 WO PCT/US2018/059894 patent/WO2019094641A1/en not_active Ceased
- 2018-11-08 CA CA3082363A patent/CA3082363A1/en active Pending
-
2020
- 2020-07-16 US US16/931,203 patent/US10961218B2/en active Active
-
2021
- 2021-02-15 US US17/175,940 patent/US11634403B2/en active Active
-
2023
- 2023-02-28 US US18/176,362 patent/US12071424B2/en active Active
- 2023-04-26 JP JP2023071977A patent/JP7535335B2/ja active Active
-
2024
- 2024-06-27 US US18/757,200 patent/US20240425477A1/en active Pending
- 2024-07-29 JP JP2024122258A patent/JP2024156774A/ja active Pending